Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
What is your treatment approach for patients with crescentic IgA nephropathy who fail to respond to cyclophosphamide and steroids?
Related Questions
In which patients with suspected IgA nephropathy and microalbuminuria would you recommend a kidney biopsy?
How long do you continue maintenance immunosuppression in a patient with PR3 ANCA glomerulonephritis with pulmonary involvement?
How do you determine duration of therapy for patients who have responded well to voclosporin therapy?
Do you assess for podocyte detachment in addition to effacement when considering the degree of glomerular injury and potential treatment options following a native kidney biopsy in a patient with proteinuria?
What is your approach for steroid dosing for patients with ANCA vasculitis on induction treatment with rituximab, avacopan, and glucocorticoid therapy?
Would you treat a patient aggressively for lupus nephritis if they have persistent proteinuria over 1 gram but cannot get a timely kidney biopsy?
What are your top takeaways from ASN 2023?
What is your approach to the use of immunosuppression for patients with poststreptococcal glomerulonephritis?
Are there instances when you recommend obtaining more than 2 kidney cores when performing a native kidney biopsy?
Do you take any special treatment considerations for elderly patients diagnosed with collapsing FSGS?
